Clinical trial
Study on Costs and Safety of Early Conversion From Intravenous to Oral…
NCT00273676 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00273676 |
|---|---|
| Title | Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia |
| Official title | Costs and Effects of Early Switch of Intravenous to Oral Antibiotics in Severe Community-Acquired Pneumonia: a Multicenter Randomized Trial |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Dutch Health Care Insurance Board |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Severe Communtity-Acquired Pneumonia |
| Intervention type | Procedure |
| Interventions | Conversion to oral antibiotic treatment after 3 days of intravenous antibiotic treatment |
| Enrollment | 500 |
| Start date | Jul 1, 2000 |
| Completion | Mar 1, 2004 |
| First posted | Jan 9, 2006 |
| Last update posted | Jan 9, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: